Segal Lloyd Mitchell
- SEC CIK
- 0001477123
No open-market purchases or sales filed in the past year.
Current role at each company
- AKTS Aktis Oncology, Inc.Directoras of Jan 12, 2026
- RPTX Repare Therapeutics Inc.PRESIDENT AND CEOas of Mar 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Segal Lloyd Mitchell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RPTX Repare Therapeutics Inc.
PRESIDENT AND CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Segal Lloyd MitchellPRESIDENT AND CEO | SSale | −21.2K | $1.14 | −$24.1K | −14.5%124.4K after | |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Segal Lloyd MitchellPRESIDENT AND CEO | SSale | −5.14K | $4.62 | −$23.8K | −4.6%107.6K after | 2 lots10b5-1 |
| Mar 27, 2024 (view filing) | Mar 25-27 | 2 days | Segal Lloyd MitchellPRESIDENT AND CEO | SSale | −7.95K | $4.69 | −$37.3K | −8.7%83.9K after | 3 lots10b5-1 |